Mortality associated with TXA was influenced by the timing of administration ( p < 0.05 ) , but any benefit was eliminated in those who required more than 2,000-mL packed red blood cells , who presented with systolic blood pressure of less than 120 mm Hg or who required OR ( all p < 0.05 ) .